Global Blood Industry to Reach $28.8 Billion in 2017: BCC Research
7/31/2013 9:37:54 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Wellesley, MA (PRWEB) July 31, 2013 -- According to a new technical market research report, THE GLOBAL BLOOD INDUSTRY (Report code: HLC008H) from BCC Research (http://www.bccresearch.com), the global market for blood products, was valued at $ 23.5 billion in 2012. BCC Research expects the market to reach more than $28.8 billion by 2017 and register a five-year compound annual growth rate (CAGR) of 4.1% for the period 2012 to 2017.
A safe and adequate blood supply is essential to the practice of modern medicine. New advances, particularly in the area of automation, have enhanced both safety and blood availability. This report details these advances and their impact on the blood industry.
The global blood market includes products used for collecting, processing and transfusing of blood, and the sale of blood therapeutics. Since BCC Research first looked at the blood products market in 2001, there have been mergers, consolidations and acquisitions among leading industry participants, including, but not limited to, Abbott, Becton, Dickinson & Co., CSL Behring, Immucor, Medimmune (AstraZeneca), Novartis, Novo Nordisk, Ortho Clinical Diagnostics, and Roche Diagnostics. In addition, advances in technology have allowed for obtaining more red blood cells from fewer donors.
Forces driving this industry are the cost of collection and processing, technological advances, an aging population, demand for plasma-derived therapeutics, and the changes in the incidence of diseases and surgical procedures and catastrophes requiring blood transfusions. According to BCC Research, the blood therapeutics market, as a segment, was valued at nearly $18.4 billion in 2012. The market is expected to reach $22.4 billion in 2017, registering a CAGR of 4.0%.
Technological advances have also allowed for greater economies and increased safety in the blood supply. The use of automated instruments is growing and is now the primary method for blood and plasma collection. Blood typing and disease screening have benefited from these advances. According to BCC Research, the market value for blood typing and screening products was nearly $2.9 billion in 2012. This market is expected to reach nearly $3.8 billion in 2017 and register a CAGR of 5.1%.
With its broad scope and in-depth analyses, this study from BCC Research covers the full range of products and services comprising the global blood industry market. The focus of the report is two-fold: first, blood for donation and the components and derived products from this blood and plasma, and second, products used to provide and support collection, processing and transfusion.
This report provides timely business and technical information that will prove valuable to a variety of readers including industry executives, managers and planners, researchers, industry analysts and investors. The projections, forecasts and trend analyses found in this report provide readers with the necessary data and information for careful decision-making.
Help employers find you! Check out all the jobs and post your resume.
comments powered by